Introgen Therapeutics, Inc. (INGN) Tops Q2 EPS by 4c, Raises Guidance

Go back to Introgen Therapeutics, Inc. (INGN) Tops Q2 EPS by 4c, Raises Guidance
INOGEN (NASDAQ: INGN) Delayed: 5.13 --0 (-0%)
Previous Close $5.13    52 Week High $64.37 
Open $5.17    52 Week Low $28.81 
Day High $5.21    P/E N/A 
Day Low $5.06    EPS $-0.36 
Volume 442,726